http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2019009213-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859399bafbd8d83a24ec70c9755c3aae
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-282
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
filingDate 2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809fa0f90968e3af081eee13ebe3f555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a450b3dbecaa93e68b287f2abba54540
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1252cb394a01e691222a430deb6dfaa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5b44d082783b24fb6a9effcbe975fea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70bf655a149aeb53fe1a364c33d68993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5157c9bd08a68be7c91081add9156754
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61df37e90663d48ed1a4436647ab209e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25dcee3820d69b603f8e2b727e5254c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c281514fa4fc687f6549179863507adb
publicationDate 2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2019009213-A
titleOfInvention COMPLEX FORMULATION INCLUDING INHIBITOR OF HMG-COA REDUCTASE AND CLOPIDOGREL.
abstract The present invention relates to a complex formulation comprising clopidogrel, an HMG-CoA reductase inhibitor and a membrane containing a hydrophobic compound. More specifically, the aim of the present invention is to provide a complex formulation comprising clopidogrel and an HMG-CoA reductase inhibitor, the complex formulation for the prevention or treatment of cardiovascular diseases, which is excellent in terms of storage stability by the prevention of degradation of the stability of an HMG-CoA reductase inhibitor.
priorityDate 2017-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606

Total number of triples: 41.